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Abstract 
Nigeria has one of the largest global HIV burdens of disease. Structured Treatment Preparation 
(STP) is required of all newly diagnosed HIV+ individuals initiating Antiretroviral Therapy 
(ART) at AIDSReleif Local Partner Treatment Facilities (LPTFs), yet no information exists on 
whether STP has any effect on a patient’s mental health. We believe that STP may be related to 
improvement in depression, anxiety, and stress scores of these individuals. A depression, 
anxiety, and stress measurement tool, (DASS) 21, was administered to patients from 6 randomly 
selected AIDSRelief LPTFs before and after the mandated 3-week STP preceding ART. Paired t-
tests were used to compare pre- and post-intervention depression, anxiety, and stress scores of all 
participants.  An analysis of variance was conducted to evaluate differences in score changes 
between LPTFs, and simple linear regressions were used to measure the correlations between age 
and (DASS) 21 score change and HIV knowledge and (DASS) 21 score change. We observed 
significant (DASS) 21 score changes for depression (p < 0.001), anxiety (p < 0.001), and stress 
(p < 0.001). Results remained significant when stratifying for gender. LPTFs DOC Kubwa [95% 
CIs: (3.42, 16.41), (2.50, 15.17), (2.22, 15.75)] and St. Gerard’s Hospital [95% CIs: (3.28, 
14.51), (2.59, 13.54), (3.81, 15.49)] demonstrated significantly greater degrees of change in 
depression, anxiety, and stress compared to St. Francis Jambutu. This study demonstrates that 
STP is associated with statistically significant changes in depression, anxiety, and stress scores 
of HIV + individuals initiating ART in Northern Nigeria. 
 
Keywords: Depression, Anxiety, Stress, HIV, Structured Treatment Preparation, (DASS) 21, 
Nigeria  
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Introduction 
Nigeria has the second highest HIV-related burden of disease in Africa and globally, and 
the number of individuals living with the virus is increasing. Nigeria has a 4% national 
prevalence rate of HIV, and 500,000 more Nigerians are living with the virus today than were 
three years ago (Josiah, 2013). Death rates attributed to the disease also increased over the same 
timeframe. Mother to child transmission accounts for approximately 10% of new cases. Rural 
residents in the Northcentral region of the country are disproportionately affected by the disease. 
Unsafe sexual practices, inept medical services, poverty, inequality, and stigma have all 
exacerbated an already grave problem (Editor [Nigeria Intel], 2014). 
Only one third of those who need treatment for HIV in Nigeria are currently receiving it. 
A mere 18% of women who are HIV positive are receiving preventive treatment for mother to 
child transmission of the disease. Over 40% of HIV infected individuals in Nigeria do not know 
they are infected (Josiah, 2013). 
For those who are diagnosed with HIV, financial hardship is unavoidable.  Morbidity, 
treatment, loss of work, and the need for increased caregiving all come with significant costs.  
Studies indicate that costs related to HIV represent from 32%-84.1% of the yearly income of 
affected households (Adedigba et al., 2009; Mahal, Canning, Odumosu, & Okonkwo, 2008). 
Costs associated with HIV extend beyond financial considerations.  Emotional costs likely exist 
for infected individuals in Nigeria, as they experience large amounts of stigma and 
discrimination (Mahal et al., 2008). 
Because HIV can be catastrophic in many facets of the lives of sufferers and their 
families, it is important to consider the mental health of infected individuals and those who care 
for them.  The link between compromised mental health and HIV in undeniable (Adewuya et al., 
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2007; Brandt, 2009).  Mental health services have not only proven to be beneficial 
psychologically, but they may also help HIV positive individuals comply with treatment (Reece, 
2003). 
Depression and anxiety are more likely in individuals infected with HIV compared to 
those in the general community.  Progression of HIV may be negatively affected by depression 
(Leserman, 2008). Though the origins of mental distress amongst this population have been 
debated, it is clear that emotional distress negatively impacts an individual’s capacity to adhere 
to treatment (Burnam et al., 2001). Depression is strongly associated with medical treatment non-
adherence, while associations between anxiety and non-adherence to medical care are not 
statistically significant (DiMatteo, Lepper, & Croghan, 2000) . Stress, also, may more strongly 
exacerbate HIV treatment non-adherence amongst those with depression compared to non-
depressed individuals (Bottonari, Safren, McQuaid, Hsiao, & Roberts, 2010). Other research 
suggests that the association between depression and non-adherence extends beyond generalized 
medical care to HIV treatment (Gonzalez, Batchelder, Psaros, & Safren, 2011).  
In addition, the negative experiences of HIV infected individuals may lead to behaviors 
that increase the risk for HIV transmission and lower the quality of life of infected patients. 
Studies suggest that social anxiety is associated with behavioral risk factors for HIV transmission 
(Hart, James, Purcell, & Farber, 2008).  A similar relationship has been observed between 
depression and HIV risk behaviors (Hutton, Lyketsos, Zenilman, Thompson, & Erbelding, 
2004).  HIV/AIDS risk is also closely linked to poverty-related stressors (Kalichman et al., 
2006). Understanding how HIV infection affects mental health is critical to providing optimal 
care to HIV positive individuals and ensuring the best health outcomes for them (Whetten, Reif, 
Whetten, & Murphy-McMillan, 2008). 
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There is considerable evidence to suggest that mental health treatment is a sensible 
component of HIV Therapy.  Although mental healthcare has proven to be an effective piece of 
HIV treatment in developed countries and the World Health Organization recommends its 
inclusion as part of care, studies concerning the link between HIV and mental illness in 
developing countries are few (Collins, Holman, Freeman, & Patel, 2006). Interventions utilizing 
social support to target depressive symptoms and increase HIV therapy adherence have been 
attempted with little effect (Simoni, Pantalone, Plummer, & Huang, 2007).   HIV positive 
individuals undergoing interpersonal psychotherapy and supportive psychotherapy with 
imipramine experienced better improvement in depression than HIV positive individuals who 
were exposed to supportive psychotherapy and cognitive behavioral therapy (Markowitz et al., 
1998). Antidepressants have been shown to be useful in treating depressed HIV positive 
individuals, though the generalizability of these findings has been called into question  
(Himelhoch & Medoff, 2005). There is a paucity of literature on interventions targeting anxiety 
or stress in HIV positive individuals. 
Individuals with mental health issues face much of the same stigma and negative 
perceptions experienced by individuals infected by HIV. These attitudes are very common in low 
and middle income countries, and Nigeria is no different (Iheanacho, Marienfeld, Stefanovics, & 
Rosenheck, 2014).  Because of this, the potential for a double stigmatization is conceivable when 
considering the prevalence of HIV patients with mental health morbidity.  Incorporation of 
mental health treatment into HIV therapy has the potential to mitigate a double burden of stigma.  
  Nigeria’s HIV-related burden of disease makes it critical that we assess the effectiveness 
of various strategies to mitigate mental distress in HIV positive populations in the country. The 
lack of research concerning mental health and HIV in developing settings makes this evaluation 
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imperative. In this study, we aimed to evaluate the effectiveness of Structured Treatment 
Preparation (STP) on depression, anxiety, and stress in HIV + individuals starting antiretroviral 
therapy (ART) in northcentral and northeastern Nigeria. STP is a three-week, four course ART 
curriculum focusing on HIV transmission, Antiretroviral drugs (ARV), ARV resistance, and side 
effects to the medication regimen. STP is required in all AIDSRelief supported LPTFs before 
patients initiate ART, so understanding exactly what implications the intervention has on 
depression, anxiety, and stress is critical, as increased numbers of newly diagnosed HIV positive 
individuals are exposed to it. AIDSRelief is a PEPFAR sponsored consortium that aims to 
provide HIV/AIDS therapy and preventive services to those in developing countries. 
Data on any pre-treatment period preceding ART is extremely limited, and, to our 
knowledge, analysis of the effect of STP on the depression, anxiety, and stress of HIV + 
individuals is non-existent. The need for understanding the effect of STP is especially important 
among a population with a high likelihood of compromised emotion state. Although the use of 
educational programs has been shown to be ineffective in treating depression (Gilbody, Whitty, 
Grimshaw, & Thomas, 2003), other studies indicate that psycho-educational interventions may 
lead to decreases in depression of HIV positive individuals starting highly active antiretroviral 
therapy (HAART) (Balfour et al., 2006).   Contradictory findings created enough equipoise for 
us to evaluate the effect that STP had on the mental health of our sample, and we were 
encouraged by the psycho-educational outcomes. With these results in mind, we hypothesized 
that STP would lower depression, anxiety, and stress symptom scores in HIV+ individuals 
initiating antiretroviral therapy in Northern Nigeria. 
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Methods 
Setting:  
Researchers from the Centre for Clinical Care and Clinical Research in Nigeria (CCCRN) 
oversaw administration of The Depression, Anxiety, and Stress Scale (DASS) 21 in six 
AIDSRelief local partner treatment facilities (LPTFs) in Northern Nigeria. Six facilities were 
randomly chosen from a list of 16, but data was not included from two of the LPTFs because of 
lack of integrity. (DASS) 21 was administered along with an HIV knowledge test before newly 
diagnosed HIV+ individuals initiated ART.  Participants at each of the sites then underwent a 
three week, four course curriculum of STP before being administered (DASS) 21 and the HIV 
knowledge test again. As part of treatment protocol at all AIDSRelief (PEPFAR) supported 
facilities, all patients newly diagnosed as HIV positive are required to undergo STP. Selection 
criteria included being diagnosed as HIV + in one of the six LPTFs.  Everyone who participated 
in the STP curriculum agreed to take the (DASS) 21 assessment.  Counselors at each of the 
treatment facilities were trained in (DASS) 21 and STP administration by the lead researcher 
from CCCRN.  Analysis was conducted on information returned from the 4 treatment centers 
returning complete data.   
Sample:  
Our sample consists of 138 recently-diagnosed HIV + individuals who were recruited 
from treatment facilities in Kaduna State, Abuja FCT, Benue State, and Adamawa State in 
northcentral and northeastern Nigeria. The sample consisted of all patients newly diagnosed as 
HIV + in the six LPTF’s randomly chosen from the 16 AIDSRelief supported facilities in the 
region. These individuals were scheduled to initiate ART for HIV in their respective LPTF. As 
part of enrollment into care at the facility, permission for the study was obtained from each 
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patient who signed a consent form. Participation in the study was voluntary and instruments were 
completed anonymously. The participants were asked not to put their names anywhere on the 
questionnaire. 
Data collection: 
(DASS) 21 was administered to the participants before a three-week, four-session STP 
for ART and again after completion of the curriculum.  Researchers compared the pre-test and 
post-test scores of all of the participants.  
Data Analysis: 
A paired t-test was used to compare pre- and post-intervention (DASS) 21 scores.  
Results were stratified by gender and test site.  An analysis of variance was conducted to 
determine if the degree of change observed at each center was the same, and simple linear 
regressions were run to analyze the association between age and (DASS) 21 score change and 
HIV Knowledge Score and (DASS) 21 score change. All data was analyzed using SAS 9.3 (SAS 
Institute). 
Results 
 We evaluated our data descriptively in order to understand more about their study 
population and identify possible results confounders and effect modifiers.  The average age of 
the study population was 34.01 years old (SD = 10.2), and included participants ranged in age 
from 12 to 64 years old (see Table 1).  The 98 female participants represented 71.01 % of the 
study population (see Table 2).  
 From the four LPTFs included this study’s analysis, 54 individuals (39.13%) participated 
from St. Gerard’s Hospital. Another 40 Individuals (28.99%) from St. Francis Jambutu 
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participated in the study, while 30 (21.74%) and 14 (10.14%) from DOC Kubwa and St. Mary’s 
Okpogba respectively contributed to study data (see Table 2).   
Overall Change in Depression, Anxiety, and Stress Scores 
 The study’s primary analysis was concerned with evaluating the change in depression, 
anxiety, and stress scores after participation in STP preceding ART (see Table 1). The pre-
intervention average (DASS) 21 depression score was 13.17 (SD = 11.43).   The post-invention 
average DASS-21 depression score was 5.68 (SD = 7.88). These scores were statistically 
significantly different (p < 0.001) and represent a categorical change in depression severity from 
mild to normal.  The pre-intervention average (DASS) 21 anxiety score was 12.13 (SD = 11.02).   
The post-invention average (DASS) 21 anxiety score was 5.77 (SD = 7.52). These scores were 
statistically significantly different (p < 0.001) and represent a categorical change in anxiety 
severity from moderate to normal.  The pre-intervention average (DASS) 21 stress score was 
13.80 (SD = 11.29).   The post-invention average (DASS) 21 stress score was 6.29 (SD = 7.99). 
These scores were statistically significantly different (p < 0.001), but they do not represent a 
categorical change in stress severity. Average pre and post-intervention depression, anxiety, and 
stress scores were statistically significantly different at each of the local partner treatment 
facilities (see Table 4).  
Change in Depression, Anxiety, and Stress Scores by Gender 
 We also conducted secondary analysis to evaluate pre- and post-intervention scores of 
depression, anxiety, and stress by gender (see Table 5).  Participating females (N = 98) had an 
average pre-intervention depression score of 13.20 (SD = 11.02). Their average post-intervention 
depression score was 5.57 (SD = 8.21).  These results were statistically significantly different (p 
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< 0.0001) and represent a categorical change in depression severity from mild to normal.  
Participating males (N = 40) had an average pre-intervention depression score of 13.10 (SD = 
12.51). Their average post-intervention depression score was 5.95 (SD = 7.07).  These results 
were statistically significantly different (p = 0.0005) and represent a categorical change in 
depression severity from mild to normal.   
 Participating females had an average pre-intervention anxiety score of 11.71 (SD = 
10.30). Their average post-intervention anxiety score was 5.57 (SD = 8.00).  These results were 
statistically significantly different (p < 0.0001) and represent a categorical change in anxiety 
severity from moderate to normal.  Participating males had an average pre-intervention anxiety 
score of 13.15 (SD = 12.69). Their average post-intervention anxiety score was 6.25 (SD = 6.25).  
These results were statistically significantly different (p = 0.0007) and represent a categorical 
change in depression severity from moderate to normal.   
 Participating females had an average pre-intervention stress score of 13.84 (SD = 10.97). 
Their average post-intervention stress score was 6.41 (SD = 8.30).  These results were 
statistically significantly different (p < 0.0001) but do not represent a categorical change in stress 
severity.   Participating males had an average pre-intervention stress score of 13.70 (SD = 12.20). 
Their average post-intervention stress score was 6.00 (SD = 7.29).  These results were 
statistically significantly different (p = 0.0004) but do not represent a categorical change in stress 
severity. Both male and female study participants presented with pre-intervention (DASS) 21 
stress scores within the normal range. 
Absolute change in depression, anxiety, and stress scores was not statistically 
significantly different between males and females. 
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Change in Depression, Anxiety, and Stress Scores by LPTF 
We also evaluated the differences in pre- and post-intervention change in depression, 
anxiety, and stress scores according to center (see Table 7).  The change in depression, anxiety, 
and stress scores at LPTF DOC Kubwa was 9.92, 8.83, and 8.98 points higher than at St. Francis 
Jambutu respectively [95% CIs: (3.42,16.41), (2.50, 15.17), (2.22, 15.75)].  The change in 
depression, anxiety, and stress scores at LPTF St. Gerard’s Hospital was 8.89, 8.06, and 9.65 
points higher than at St. Francis Jambutu respectively [95% CIs: (3.28,14.51), (2.59, 13.54), 
(3.81, 15.49)] (Table 4). 
Change in Depression, Anxiety, & Stress Score by HIV Knowledge   
We observed a weak correlation between change in stress scores and pre-intervention 
HIV knowledge scores (r = 0.07; SE = 0.05), but these results were not statistically significant (p 
= 0.20). Pre-intervention HIV knowledge scores were negatively correlated with change in 
depression (r = -0.01; SE = 0.05) and anxiety (r = -0.01; SE = 0.05) scores, but these results were 
not statistically significant (p = 0.84; p = 0.82). Post-intervention HIV knowledge score is 
significantly associated with change in stress (p = 0.03), but the negative correlation was weak (r 
= -0.22; SE = 0.10). Depression (r = -0.16; SE = 0.09) and anxiety (r = -0.15; SE = 0.09) score 
changes were negatively correlated with post-intervention HIV knowledge scores, but these 
results were not statistically significant (p = 0.09; p = 0.09).  We observed a significant negative 
correlation (r = -0.11; SE = 0.05) between change in stress score and change in HIV knowledge 
score (p = 0.02). There was also a negative correlation between change in depression (r = -0.03; 
SE = 0.05) and anxiety (r = -0.03; SE = 0.04) scores and change in HIV knowledge, but these 
results were not statistically significant (p = 0.51; p = 0.53) (see Table 8).  
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Change in Depression, Anxiety, & Stress Score by Age  
We found no association between (DASS) 21 score change and age. 
Overall, our results support our hypothesis that STP is associated with statistically 
significant changes in depression, anxiety, and stress scores of HIV + individuals initiating ART.   
Discussion 
 This study demonstrates that STP is associated with statistically significant changes in 
depression, anxiety, and stress scores of HIV + individuals initiating ART.  For depression and 
anxiety, the changes in score represented categorical changes in mental symptom severity.  This 
was not the case for stress, however, as average pre-intervention stress scores for study 
participants were not elevated above the normal range.  The same trends were observed when we 
stratified the study sample by gender. An analysis of mental health symptoms by LPTF showed 
that participants at Doc Kubwa and St. Gerard’s Hospital had statistically significantly greater 
changes in mood than participants at St. Francis Jambutu. 
 This study helps expand the scant literature on HIV/mental health associations in the 
developing world. Knowing that mental health care is already recommended as critical to HIV 
therapy in developed countries, it stands to reason that the same would be true in countries with 
emerging economies.  It is necessary, however, to form an evidence base to support this 
supposition, and this research contributes to that aim. 
 To our knowledge, this is the first study to examine the effect of STP on the depression, 
anxiety, and stress scores of HIV + individuals initiating ART. The relationship between STP 
and depression, anxiety, and stress is particularly important because STP is mandated in all 
LPTFs supported by AIDSRelief. Thus, our findings have the potential to affect hundreds of 
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thousands of individuals who have already learned from the curriculum. More HIV positive 
individuals will benefit from this information as AIDSRelief serves more patients and expands in 
future years. Our research also contributes to the unsubstantial literature surrounding the mental 
health, specifically depression, anxiety, and stress, of HIV positive individuals in developing 
countries.   
Evidence suggests that mental health symptoms are associated with a decreased ability to 
adhere to HIV therapy (Mellins, Kang, Leu, Havens, & Chesney, 2003).  Because of this, any 
efforts to minimize compromised mental health among HIV + individuals is of the utmost 
importance and may help reduce the chance of infected individuals progressing to AIDS 
development (Bangsberg et al., 2001). This trend is reversed, however, when clients undergo 
mental health therapy, and those being treated for mental illnesses are more likely to make use of 
ART (Cook et al., 2002). Finally, in sub-Saharan Africa where ART retention rates are already 
being targeted for improvement, any strategy that may improve retention must be thoroughly 
understood (Fox & Rosen, 2010; Rosen, Fox, & Gill, 2007). Thus, if STP helps alleviate 
depression, anxiety, and stress, then its potential for increasing adherence to ART in the region 
and beyond must not be understated. STP has the potential to make ART more effective for those 
using it, which will ultimately lead to better health outcomes for millions of potential curriculum 
participants.   
This study has several strengths.  Primarily, it contributes to the scant literature 
evaluating the link between mental health and HIV in the developing world.  To our knowledge, 
this research is the first to study the effect of STP on the depression, anxiety, and stress of HIV 
positive individuals initiating ART.  This is important in Nigeria, the country with the second 
highest HIV burden in the world, and our findings may be able to be generalized to individuals in 
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all AIDSRelief sponsored LPTFs.  Our research has the potential to improve ART adherence and 
the health outcomes of hundreds of thousands of HIV positive individuals in Africa and other 
regions of the developing world.  
  Our study is not without limitations.  First, its quasi-experimental design lacks 
systematic randomization, which may jeopardize its internal validity. It is also difficult to 
identify whether STP has a causal relationship with the decrease in depression, anxiety, and 
stress scores or if our results can be attributed to confounding variables. The lack of covariates 
and demographic information on study participants makes it difficult to conduct potentially 
interesting and valuable research.  Next, a larger sample size would have been beneficial. 
Information from two of the LPTFs originally intended for analysis was discarded for lack of 
integrity, decreasing the study’s sample size and power.  There is no comparison group in our 
study, so it is unclear if similar improvement in mood could have resulted without STP.  In 
addition, the researcher primarily responsible for the drafting this manuscript was not part of the 
team that designed the study and collected data, and this disconnect could pose obvious 
challenges.   
 Finally, this study serves as impetus for a number of future research directions.  The 
scope of this project was limited to northcentral and northeast Nigeria. It is important to 
understand if STP is associated with depression, anxiety, and stress score improvement in the 
four remaining regions of the country and in other regions of African and the developing world.  
Efforts should also be made to conduct randomized research in patient populations about which 
we have more demographic information. Knowing more about rurality, religion, familial and 
employment status, income, tribal associations, etc. . . . would be beneficial beyond 
understanding the effect that STP has on the depression, anxiety, and stress scores of HIV + 
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individuals.  This information would also offer a deeper understanding of the association of 
different demographic variables on mental health in Nigerians and, ideally, individuals from 
other countries in the region. It seems counterintuitive that HIV individuals would present with 
average stress scores in the normal range. Further investigation into the stress levels of recently 
diagnosed HIV positive individuals may demonstrate interesting findings for providers and 
policy makers pursuing the most effective mental health treatment for these patients. There are 
also valuable research opportunities stemming from the difference in absolute score change 
observed at the four LPTFs that were part of the study.  It is clear that differences existed in the 
degree of change that the intervention provided at the treatment centers, yet the reason for these 
differences is unclear.  Further investigation into this question would allow HIV and mental 
health practitioners alike to deliver the most effective care. 
 In conclusion, STP seems effective in lowering depression, anxiety, and stress scores in 
HIV+ individuals initiating antiretroviral therapy in Northern Nigeria. Because mental health 
care is part of the international standard for HIV therapy provision, it is important to understand 
more about what is being done to address compromised mental health in HIV positive 
individuals in the developing world, where such information is severely lacking. By 
demonstrating that STP is associated with improved depression, anxiety, and stress scores, it 
seems likely the curriculum may increase adherence to HIV therapy.  The potential health 
outcomes that could result from increased adherence will affect hundreds of thousands of HIV 
patients worldwide and have ability impact many more. In a country like Nigeria, with the 
second highest global burden of HIV, the potential upside of understanding the association 
between STP and mental health is invaluable. Because STP is required by all AIDSRelief-
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sponsored LPTFs, the implications of this research extend well beyond Northern Nigeria and 
represent an important move toward meeting universal HIV therapy recommendations.  
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Table 1. Distribution of Age, Pre- and Post-Intervention Depression, Anxiety, and Stress Scores in 138 HIV+ Patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Distribution of Sex and Local Partner Treatment Facility in 138 HIV+ Patients. 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics Mean Standard deviation Median Minimum Maximum 
Age 34.01 10.20 33.00 12.00 64.00 
Pre-intervention 
depression score 13.17 11.43 10.00 0.00 42.00 
Pre-intervention 
anxiety score 12.13 11.02 8.00 0.00 42.00 
Pre-intervention 
stress score 13.80 11.29 11.00 0.00 42.00 
Post-intervention 
depression score 5.68 7.88 2.00 0.00 42.00 
Post-intervention 
anxiety score 5.77 7.52 4.00 0.00 42.00 
Post-intervention 
stress score 6.29 7.99 4.00 0.00 42.00 
Sex N % 
Male 40 28.99 
Female 98 71.01 
LPTF N % 
St. Gerards Hospital 54 39.13 
St. Mary Okpogba  14 10.14 
St. Francis Jambutu 40 28.99 
DOC Kubwa 30 21.74 
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 Table 3. Distribution of Age, Pre- and Post-Intervention Depression, Anxiety, and Stress Scores in 138 HIV+ Patients by 
Gender. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics 
(Male; N=40) 
Mean Standard deviation Minimum Maximum 
Pre-intervention 
depression score 13.10 12.51 0.00 42.00 
Pre-intervention 
anxiety score 13.15 12.69 0.00 42.00 
Pre-intervention 
stress score 13.70 12.20 0.00 42.00 
Post-intervention 
depression score 5.95 7.07 0.00 28.00 
Post-intervention 
anxiety score 6.25 6.25 0.00 22.00 
Post-intervention 
stress score 6.00 7.29 0.00 26.00 
Change in 
depression score -7.15 11.80 -42.00 8.00 
Change in anxiety 
score -6.90 11.84 -42.00 6.00 
Change in stress 
score -7.70 11.80 -42.00 18.00 
Characteristics 
(Female; N=98) 
Mean Standard deviation Minimum Maximum 
Pre-intervention 
depression score 13.20 11.02 0.00 42.00 
Pre-intervention 
anxiety score 11.71 10.30 0.00 42.00 
Pre-intervention 
stress score 13.84 10.97 0.00 42.00 
Post-intervention 
depression score 5.57 8.21 0.00 42.00 
Post-intervention 
anxiety score 5.77 8.00 0.00 42.00 
Post-intervention 
stress score 6.41 8.30 0.00 42.00 
Change in 
depression score -7.63 10.82 -40.00 42.00 
Change in anxiety 
score -6.14 10.17 -38.00 42.00 
Change in stress 
score -7.43 11.11 -42.00 42.00 
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Table 4. Overall and Treatment Facility–Specific Depression, Anxiety, and Stress Score Change 
 
 
Mental Health 
Symptom 
 
 
Local Partner 
Treatment Facility 
(LPTF) 
 
Average Health Score by LPTF 
 
 
 
P-value 
 
Average Overall Health Score  
 
 
 
P-value 
 
Pre-intervention 
 
Post-intervention 
 
Pre-intervention 
 
 
Post-intervention 
 
 
Depression 
St Gerards Hosp. 9.19 9.18 <.0001  
 
13.17 
 
 
5.68 
 
 
<.0001 
St Mary Okpoga 15.57 5.29 0.0002 
St Francis Jambutu 18.60 5.15 <.0001 
DOC Kubwa. 12.00 8.47 0.0249 
 
Anxiety 
St Gerards Hosp. 9.07 5.03 0.0002  
 
12.13 
 
 
5.77 
 
 
<.0001 
St Mary Okpoga 9.43 3.86 0.0019 
St Francis Jambutu 18.00 5.90 <.0001 
DOC Kubwa. 11.07 7.80 0.0125 
 
Stress 
St Gerards Hosp. 9.07 5.07 <.0001  
 
13.80 
 
 
6.29 
 
 
<.0001 
St Mary Okpoga 15.86 6.29 <.0001 
St Francis Jambutu 19.80 6.15 <.0001 
DOC Kubwa. 13.33 8.67 0.0054 
  
P value is based on t-test. 
 
 
 
 
 
 
 
Table 5. Gender-Specific Depression, Anxiety, and Stress Score Change 
 Gender Average Health Score P value Change P value 
Pre-intervention Post-intervention 
Depression Male 13.10 5.95 0.0005 -7.15 0.4879 
Female 13.20 5.57 <.0001 -7.63 
Anxiety Male 13.15 6.25 0.0007 -6.90 0.2340 
Female 11.71 5.57 <.0001 -6.14 
Stress Male 13.70 6.00 0.0004 -7.70 0.9001 
Female 13.84 6.41 <.0001 -7.43 
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Table 6. Local Partner Treatment Facility Pairwise Comparison of Depression, Anxiety, and Stress Score 
Change 
 
 
Mental Health 
Symptom 
 
 
Local Partner 
Treatment Facility 
(LPTF) 
 
Average Health Score by LPTF 
 
 
 
P-value 
 
 
Intra-LPTF Average Score Change 
 
 
 
P-value 
 
Pre-intervention 
 
Post-intervention 
 
 
 
 
-4.56 
-10.29 
-13.45 
-3.53 
-4.04 
-5.57 
-12.10 
-3.27 
-4.00 
-9.57 
-13.65 
-4.67 
 
Depression 
St Gerards Hosp. 9.19 9.18 <.0001  
 
<.0001 
St Mary Okpoga 15.57 5.29 0.0002 
St Francis Jambutu 18.60 5.15 <.0001 
DOC Kubwa. 12.00 8.47 0.0249 
 
Anxiety 
St Gerards Hosp. 9.07 5.03 0.0002  
 
<.0001 
St Mary Okpoga 9.43 3.86 0.0019 
St Francis Jambutu 18.00 5.90 <.0001 
DOC Kubwa. 11.07 7.80 0.0125 
 
Stress 
St Gerards Hosp. 9.07 5.07 <.0001  
 
<.0001 
St Mary Okpoga 15.86 6.29 <.0001 
St Francis Jambutu 19.80 6.15 <.0001 
DOC Kubwa. 13.33 8.67 0.0054 
  
The second P-value is based on inter-center ANOVA 
The change in depression, anxiety, and stress was highest in the LPTF St. Francis Jambutu and lowest in LPTF DOC. Kubwa.  
 
 
Table 7. Significant Results of Pairwise Comparison from Table 6 
 
 
LPTF 
Comparison 
Depression Anxiety       Stress 
Difference  95% 
Confidence 
Interval 
Difference 95% 
Confidence 
Interval 
Difference 95% 
Confidence 
Interval 
   
DOC. Kubwa – 
St. Francis 
Jambutu 
 
St. Gerard’s 
Hospital 
9.92 
 
 
 
8.89 
3.42 
 
 
 
3.28  
16.41 
 
 
 
14.51 
8.83 2.50 15.17 8.98 2.22 15.75 
   
    
 
8.06                        
 
2.59 
 
13.54 
 
9.65 
 
3.81 
 
15.49 
    
 
 
 
Table 8. Change in Depression, Anxiety, and Stress by HIV Knowledge Score 
Mental Health Symptom HIV Knowledge Pre-Test HIV Knowledge Post-Test Change in HIV Knowledge Score  
 Score (SE) P value Score (SE) P value Score (SE) P value 
Depression  -0.01 (0.05) 0.836 -0.16 (0.09) 0.086 -0.03 (0.05) 0.507 
Anxiety -0.01 (0.05) 0.824 -0.15 (0.09) 0.093 -0.03 (0.04) 0.528 
Stress 0.07 (0.05) 0.201 -0.22 (0.10) 0.026 -0.11 (0.05) 0.022 
 
